Literature DB >> 19095373

Target definition by C11-methionine-PET for the radiotherapy of brain metastases.

Masayuki Matsuo1, Kazuhiro Miwa, Jun Shinoda, Nobuo Kako, Hironori Nishibori, Kouta Sakurai, Hirohito Yano, Toru Iwama, Masayuki Kanematsu.   

Abstract

PURPOSE: To evaluate the ability of 11C-methionine positron emission tomography (MET-PET) to delineate target volumes for brain metastases and to investigate to what extent tumor growth is presented by magnetic resonance imaging (MRI) and MET-PET.
MATERIALS AND METHODS: Three observers undertook target definition in 19 patients with 95 brain metastases by MRI and MET-PET images. MRI gross target volume (GTV) (GTV-MRI) was defined as the contrast-enhanced area on gadolinium-enhanced T1-weighted MRI. MET-PET GTV (GTV-PET) was defined as the area of an accumulation of MET-PET apparently higher than that of normal tissue on MET-PET images. The size of occupation ratio was determined using the following equation: SOR (%) of MET are within x mm margin outside GTV-MRI = the volume of the GTV-PET within x mm outside the GTV-MRI/the volume of the GTV-PET.
RESULTS: For GTV-MRI volumes of <or=0.5 mL, the sensitivity of tumor detection by MET-PET was 43%. For GTV-MRI volume of >0.5 mL, GTV-PET volumes were larger than GTV-MRI volumes and a significant correlation was found between these variables by linear regression. For all tumor sizes and tumor characteristics, a 2-mm margin outside the GTV-MRI significantly improved the coverage of the GTV-PET.
CONCLUSIONS: Although there were some limitations in our study associated with spatial resolution, blurring effect, and image registrations with PET images, MET-PET was supposed to have a potential as a promising tool for the precise delineation of target volumes in radiotherapy planning for brain metastases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095373     DOI: 10.1016/j.ijrobp.2008.08.056

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Value of 11C-methionine PET in imaging brain tumours and metastases.

Authors:  Andor W J M Glaudemans; Roelien H Enting; Mart A A M Heesters; Rudi A J O Dierckx; Ronald W J van Rheenen; Annemiek M E Walenkamp; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-12       Impact factor: 9.236

Review 2.  [PET/CT for diagnostics and therapy stratification of lung cancer].

Authors:  C Kratochwil; U Haberkorn; F L Giesel
Journal:  Radiologe       Date:  2010-08       Impact factor: 0.635

Review 3.  Imaging biomarkers in primary brain tumours.

Authors:  Egesta Lopci; Ciro Franzese; Marco Grimaldi; Paolo Andrea Zucali; Pierina Navarria; Matteo Simonelli; Lorenzo Bello; Marta Scorsetti; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-18       Impact factor: 9.236

4.  Differentiation of glioblastomas from metastatic brain tumors by tryptophan uptake and kinetic analysis: a positron emission tomographic study with magnetic resonance imaging comparison.

Authors:  David O Kamson; Sandeep Mittal; Amy Buth; Otto Muzik; William J Kupsky; Natasha L Robinette; Geoffrey R Barger; Csaba Juhász
Journal:  Mol Imaging       Date:  2013 Jul-Aug       Impact factor: 4.488

5.  Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm.

Authors:  Tomohiko Yamane; Setsu Sakamoto; Michio Senda
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-14       Impact factor: 9.236

6.  11C-methionine- and 18F-FDG-PET double-negative metastatic brain tumor from lung adenocarcinoma with paradoxical high 18F-FDG uptake: A case report.

Authors:  Kuniaki Tanahashi; Masaki Hirano; Lushun Chalise; Takahiko Tsugawa; Yuka Okumura; Tetsunari Hase; Fumiharu Ohka; Kazuya Motomura; Kazuhito Takeuchi; Yuichi Nagata; Norimoto Nakahara; Naozumi Hashimoto; Ryuta Saito
Journal:  Surg Neurol Int       Date:  2022-08-19

7.  Determination of optimal virtual monochromatic energy level for target delineation of brain metastases in radiosurgery using dual-energy CT.

Authors:  Tsukasa Karino; Shingo Ohira; Naoyuki Kanayama; Kentaro Wada; Toshiki Ikawa; Yuya Nitta; Hayate Washio; Masayoshi Miyazaki; Teruki Teshima
Journal:  Br J Radiol       Date:  2019-12-20       Impact factor: 3.039

Review 8.  SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.

Authors:  Barbara Palumbo; Tommaso Buresta; Susanna Nuvoli; Angela Spanu; Orazio Schillaci; Mario Luca Fravolini; Isabella Palumbo
Journal:  Int J Mol Sci       Date:  2014-06-03       Impact factor: 5.923

9.  Prospective study of 11C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment.

Authors:  Shoji Yomo; Kazuhiro Oguchi
Journal:  BMC Cancer       Date:  2017-11-06       Impact factor: 4.430

10.  Co-imaging of the tumor oxygenation and metabolism using electron paramagnetic resonance imaging and 13-C hyperpolarized magnetic resonance imaging before and after irradiation.

Authors:  Masayuki Matsuo; Tatsuya Kawai; Shun Kishimoto; Keita Saito; Jeeva Munasinghe; Nallathamby Devasahayam; James B Mitchell; Murali C Krishna
Journal:  Oncotarget       Date:  2018-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.